Human papillomavirus type 16 E7 oncoprotein inhibits the anaphase promoting complex/cyclosome activity by dysregulating EMI1 expression in mitosis

Virology

Volumn 446, Issue 1-2, 2013, Pages 251-259

  Yu, Yueyang ^a   Munger, Karl ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Anaphase Promoting Complex Cyclosome (APC C); Cervical cancer; E7 oncoprotein; EMI1; Genomic instability; Human papillomaviruses; Mitosis

Indexed keywords

ANAPHASE PROMOTING COMPLEX; CYCLIN A; EARLY MITOTIC INHIBITOR 1; INHIBITOR PROTEIN; NEK2A PROTEIN; PEVONEDISTAT; PROTEIN E7; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROMETAPHASE; PROTEIN DEGRADATION; PROTEIN STABILITY;

ANAPHASE PROMOTING COMPLEX/CYCLOSOME (APC/C); CERVICAL CANCER; E7 ONCOPROTEIN; EMI1; GENOMIC INSTABILITY; HUMAN PAPILLOMAVIRUSES; MITOSIS;

CELL CYCLE PROTEINS; CELLS, CULTURED; F-BOX PROTEINS; GENE EXPRESSION PROFILING; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MITOSIS; PAPILLOMAVIRUS E7 PROTEINS; PROTEOLYSIS; RNA, MESSENGER; UBIQUITIN-PROTEIN LIGASE COMPLEXES;

EID: 84884545242     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.08.013     Document Type: Article

References (67)

1. Balczon R.C. Overexpression of cyclin A in human HeLa cells induces detachment of kinetochores and spindle pole/centrosome overproduction. Chromosoma 2001, 110:381-392.
2. Ban K.H., Torres J.Z., Miller J.J., Mikhailov A., Nachury M.V., Tung J.J., Rieder C.L., Jackson P.K. The END network couples spindle pole assembly to inhibition of the anaphase-promoting complex/cyclosome in early mitosis. Dev. cell 2007, 13:29-42.
3. Bellanger S., Blachon S., Mechali F., Bonne-Andrea C., Thierry F. High-risk but not low-risk HPV E2 proteins bind to the APC activators Cdh1 and Cdc20 and cause genomic instability. Cell Cycle 2005, 4:1608-1615.
4. Boyer S.N., Wazer D.E., Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 1996, 56:4620-4624.
5. Carter S.L., Eklund A.C., Kohane I.S., Harris L.N., Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 2006, 38:1043-1048.
6. Di Fiore B., Pines J. Emi1 is needed to couple DNA replication with mitosis but does not regulate activation of the mitotic APC/C. J. Cell Biol. 2007, 177:425-437.
7. Duda D.M., Borg L.A., Scott D.C., Hunt H.W., Hammel M., Schulman B.A. Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation. Cell 2008, 134:995-1006.
8. Duensing S., Lee L.Y., Duensing A., Basile J., Piboonniyom S., Gonzalez S., Crum C.P., Munger K. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc. Natl. Acad. Sci. USA 2000, 97:10002-10007.
9. Duensing S., Munger K. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res. 2002, 62:7075-7082.
10. Engelbert D., Schnerch D., Baumgarten A., Wasch R. The ubiquitin ligase APC(Cdh1) is required to maintain genome integrity in primary human cells. Oncogene 2008, 27:907-917.
11. Fehr A.R., Yu D. Control the host cell cycle: viral regulation of the anaphase-promoting complex. J. Virol. 2013, 87:8818-8825.
12. Frye J.J., Brown N.G., Petzold G., Watson E.R., Grace C.R., Nourse A., Jarvis M.A., Kriwacki R.W., Peters J.M., Stark H., Schulman B.A. Electron microscopy structure of human APC/C-EMI1 reveals multimodal mechanism of E3 ligase shutdown. Nat. Struct. Mol. Biol. 2013.
13. Garcia-Higuera I., Manchado E., Dubus P., Canamero M., Mendez J., Moreno S., Malumbres M. Genomic stability and tumour suppression by the APC/C cofactor Cdh1. Nat. Cell Biol. 2008, 10:802-811.
14. Gonzalez S.L., Stremlau M., He X., Basile J.R., Munger K. Degradation of the retinoblastoma tumor suppressor by the human papillo- mavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. J. Virol. 2001, 75:7583-7591.
15. Guardavaccaro D., Kudo Y., Boulaire J., Barchi M., Busino L., Donzelli M., Margottin-Goguet F., Jackson P.K., Yamasaki L., Pagano M. Control of meiotic and mitotic progression by the F box protein beta-Trcp1 in vivo. Dev. Cell 2003, 4:799-812.
16. Hansen D.V., Loktev A.V., Ban K.H., Jackson P.K. Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFbetaTrCP-dependent destruction of the APC Inhibitor Emi1. Mol. Biol. Cell 2004, 15:5623-5634.
17. Hayward D.G., Clarke R.B., Faragher A.J., Pillai M.R., Hagan I.M., Fry A.M. The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer. Cancer Res. 2004, 64:7370-7376.
18. Heilman D.W., Green M.R., Teodoro J.G. The anaphase promoting complex: a critical target for viral proteins and anti-cancer drugs. Cell Cycle 2005, 4:560-563.
19. Hsu J.Y., Reimann J.D., Sorensen C.S., Lukas J., Jackson P.K. E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC(Cdh1). Nat. Cell Biol. 2002, 4:358-366.
20. Huh K., Zhou X., Hayakawa H., Cho J.Y., Libermann T.A., Jin J., Harper J.W., Munger K. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J. Virol. 2007, 81:9737-9747.
21. Jackman M., Lindon C., Nigg E.A., Pines J. Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat. Cell Biol. 2003, 5:143-148.
22. Jeganathan K.B., Malureanu L., van Deursen J.M. The Rae1-Nup98 complex prevents aneuploidy by inhibiting securin degradation. Nature 2005, 438:1036-1039.
23. Kitagawa M., Hatakeyama S., Shirane M., Matsumoto M., Ishida N., Hattori K., Nakamichi I., Kikuchi A., Nakayama K. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO J. 1999, 18:2401-2410.
24. Klingelhutz A.J., Roman A. Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses. Virology 2012, 424:77-98.
25. Kraft C., Herzog F., Gieffers C., Mechtler K., Hagting A., Pines J., Peters J.M. Mitotic regulation of the human anaphase-promoting complex by phosphorylation. EMBO J. 2003, 22:6598-6609.
26. Lehman N.L., Tibshirani R., Hsu J.Y., Natkunam Y., Harris B.T., West R.B., Masek M.A., Montgomery K., van de Rijn M., Jackson P.K. Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors. Am. J. Pathol. 2007, 170:1793-1805.
27. Lehman N.L., Verschuren E.W., Hsu J.Y., Cherry A.M., Jackson P.K. Overexpression of the anaphase promoting complex/cyclosome inhibitor Emi1 leads to tetraploidy and genomic instability of p53-deficient cells. Cell Cycle 2006, 5:1569-1573.
28. Lenart P., Petronczki M., Steegmaier M., Di Fiore B., Lipp J.J., Hoffmann M., Rettig W.J., Kraut N., Peters J.M. The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1. Curr. Biol.: CB 2007, 17:304-315.
29. Lipkowitz S., Weissman A.M. RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat. Rev. Cancer 2011, 11:629-643.
30. Margottin-Goguet F., Hsu J.Y., Loktev A., Hsieh H.M., Reimann J.D., Jackson P.K. Prophase destruction of Emi1 by the SCF(betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev. Cell 2003, 4:813-826.
31. McLaughlin-Drubin M.E., Huh K.W., Munger K. Human papillomavirus type 16 E7 oncoprotein associates with E2F6. J. Virol. 2008, 82:8695-8705.
32. McLaughlin-Drubin M.E., Meyers J., Munger K. Cancer associated human papillomaviruses. Curr. Opinion Virol. 2012, 2:459-466.
33. McLaughlin-Drubin M.E., Munger K. The human papillomavirus E7 oncoprotein. Virology 2009, 384:335-344.
34. McLaughlin-Drubin M.E., Munger K. Oncogenic activities of human papillomaviruses. Virus Res. 2009, 143:195-208.
35. Meraldi P., Honda R., Nigg E.A. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J. 2002, 21:483-492.
36. Miller J.J., Summers M.K., Hansen D.V., Nachury M.V., Lehman N.L., Loktev A., Jackson P.K. Emi1 stably binds and inhibits the anaphase-promoting complex/cyclosome as a pseudosubstrate inhibitor. Genes Dev. 2006, 20:2410-2420.
37. Mo M., Shahar S., Fleming S.B., Mercer A.A. How viruses affect the cell cycle through manipulation of the APC/C. Trends Microbiol. 2012.
38. Moody C.A., Laimins L.A. Human papillomavirus oncoproteins: pathways to transformation. Nat. Rev. Cancer 2010, 10:550-560.
39. Moshe Y., Bar-On O., Ganoth D., Hershko A. Regulation of the action of early mitotic inhibitor 1 on the anaphase-promoting complex/cyclosome by cyclin-dependent kinases. J. Biol. Chem. 2011, 286:16647-16657.
40. Moshe Y., Boulaire J., Pagano M., Hershko A. Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome. Proc.Natl. Acad. Sci. USA 2004, 101:7937-7942.
41. Mundt K.E., Golsteyn R.M., Lane H.A., Nigg E.A. On the regulation and function of human polo-like kinase 1 (PLK1): effects of overexpression on cell cycle progression. Biochem. Biophys. Res. Commun. 1997, 239:377-385.
42. Munger K., Baldwin A., Edwards K.M., Hayakawa H., Nguyen C.L., Owens M., Grace M., Huh K. Mechanisms of human papillomavirus-induced oncogenesis. J. Virol. 2004, 78:11451-11460.
43. Musacchio A., Salmon E.D. The spindle-assembly checkpoint in space and time. Nat. Rev. Mol. Cell Biol. 2007, 8:379-393.
44. Nakayama K.I., Nakayama K. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin. Cell Dev. Biol. 2005, 16:323-333.
45. Nakayama K.I., Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer 2006, 6:369-381.
46. Nguyen C.L., Eichwald C., Nibert M.L., Munger K. Human papillomavirus type 16 E7 oncoprotein associates with the centrosomal component gamma-tubulin. J. Virol. 2007, 81:13533-13543.
47. Nguyen C.L., Munger K. Human papillomavirus E7 protein deregulates mitosis via an association with nuclear mitotic apparatus protein 1. J. Virol. 2009, 83:1700-1707.
48. Oh K.J., Kalinina A., Wang J., Nakayama K., Nakayama K.I., Bagchi S. The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin 1- and Skp2-containing E3 ligase. J. Virol. 2004, 78:5338-5346.
49. Peters J.M. The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat. Rev. Mol. Cell Biol. 2006, 7:644-656.
50. Piboonniyom S.O., Duensing S., Swilling N.W., Hasskarl J., Hinds P.W., Munger K. Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability. Cancer Res. 2003, 63:476-483.
51. Pines J. Cubism and the cell cycle: the many faces of the APC/C. Nature reviews. Mol. Cell Biol. 2011, 12:427-438.
52. Podust V.N., Brownell J.E., Gladysheva T.B., Luo R.S., Wang C., Coggins M.B., Pierce J.W., Lightcap E.S., Chau V. A Nedd8 conjugation pathway is essential for proteolytic targeting of p27Kip1 by ubiquitination. Proc. Natl. Acad. Sci. USA 2000, 97:4579-4584.
53. Read M.A., Brownell J.E., Gladysheva T.B., Hottelet M., Parent L.A., Coggins M.B., Pierce J.W., Podust V.N., Luo R.S., Chau V., Palombella V.J. Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalpha. Mol. Cell. Biol. 2000, 20:2326-2333.
54. Reimann J.D., Freed E., Hsu J.Y., Kramer E.R., Peters J.M., Jackson P.K. Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Cell 2001, 105:645-655.
55. Reimann J.D., Gardner B.E., Margottin-Goguet F., Jackson P.K. Emi1 regulates the anaphase-promoting complex by a different mechanism than Mad2 proteins. Genes Dev. 2001, 15:3278-3285.
56. Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993, 75:495-505.
57. Song M.S., Song S.J., Ayad N.G., Chang J.S., Lee J.H., Hong H.K., Lee H., Choi N., Kim J., Kim H., Kim J.W., Choi E.J., Kirschner M.W., Lim D.S. The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat. Cell Biol. 2004, 6:129-137.
58. Soucy T.A., Smith P.G., Milhollen M.A., Berger A.J., Gavin J.M., Adhikari S., Brownell J.E., Burke K.E., Cardin D.P., Critchley S., Cullis C.A., Doucette A., Garnsey J.J., Gaulin J.L., Gershman R.E., Lublinsky A.R., McDonald A., Mizutani H., Narayanan U., Olhava E.J., Peluso S., Rezaei M., Sintchak M.D., Talreja T., Thomas M.P., Traore T., Vyskocil S., Weatherhead G.S., Yu J., Zhang J., Dick L.R., Claiborne C.F., Rolfe M., Bolen J.B., Langston S.P. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 2009, 458:732-736.
59. Spardy N., Covella K., Cha E., Hoskins E.E., Wells S.I., Duensing A., Duensing S. Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin. Cancer Res. 2009, 69:7022-7029.
60. Suijkerbuijk S.J., Kops G.J. Preventing aneuploidy: the contribution of mitotic checkpoint proteins. Biochim. Biophys. Acta 2008, 1786:24-31.
61. van Vugt M.A., van de Weerdt B.C., Vader G., Janssen H., Calafat J., Klompmaker R., Wolthuis R.M., Medema R.H. Polo-like kinase-1 is required for bipolar spindle formation but is dispensable for anaphase promoting complex/Cdc20 activation and initiation of cytokinesis. J.Biol. Chem. 2004, 279:36841-36854.
62. van Zon W., Wolthuis R.M. Cyclin A and Nek2A: APC/C-Cdc20 substrates invisible to the mitotic spindle checkpoint. Biochem. Soc. Trans. 2010, 38:72-77.
63. Wang W., Kirschner M.W. Emi1 preferentially inhibits ubiquitin chain elongation by the anaphase-promoting complex. Nat. Cell Biol. 2013.
64. Watanabe N., Arai H., Iwasaki J., Shiina M., Ogata K., Hunter T., Osada H. Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways. Proc. Natl. Acad. Sci. USA 2005, 102:11663-11668.
65. White E.A., Sowa M.E., Tan M.J., Jeudy S., Hayes S.D., Santha S., Munger K., Harper J.W., Howley P.M. Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses. Proc. Natl. Acad. Sci. USA 2012, 109:E260-267.
66. Winkler B., Crum C.P., Fujii T., Ferenczy A., Boon M., Braun L., Lancaster W.D., Richart R.M. Koilocytotic lesions of the cervix. The relationship of mitotic abnormalities to the presence of papillomavirus antigens and nuclear DNA content. Cancer 1984, 53:1081-1087.
67. Yu Y., Munger K. Human papillomavirus type 16 E7 oncoprotein engages but does not abrogate the mitotic spindle assembly checkpoint. Virology 2012, 432:120-126.